HANMI PHARM. IND. CO. LTD.
|HANMI PHARM. IND. CO. LTD. Patent applications|
|Patent application number||Title||Published|
|20090238838||INSULINOTROPIC PEPTIDE CONJUGATE USING AN IMMUNOGLOBULIN FC - The present invention relates to an insulinotropic peptide conjugate having improved in-vivo duration of efficacy and stability, comprising an insulinotropic peptide, a non-peptide polymer and a carrier substance, which are covalently linked to each other, and a use of the same. The insulinotropic peptide conjugate of the present invention has the in-vivo activity which is maintained relatively high, and has remarkably increased blood half-life, and thus it can be desirably employed in the development of long acting formulations of various peptide drugs.||09-24-2009|
Patent applications by HANMI PHARM. IND. CO. LTD.